EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 28 / No 8-9 (Août–Septembre 2012) Med Sci (Paris), 28 8-9 (2012) 757-763 References
Free Access
Issue
Med Sci (Paris)
Volume 28, Number 8-9, Août–Septembre 2012
Page(s) 757 - 763
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012288018
Published online 22 August 2012
  1. Salomon B. Les lymphocytes T régulateurs CD4+CD25+ : vers une immuno-modulation thérapeutique ?. Med Sci (Paris) 2002 ; 18 : 1066–1068. [CrossRef] [EDP Sciences] [Google Scholar]
  2. Joffre O, Santolaria T, van Meerwijk JP. Utilisation des lymphocytes T régulateurs en transplantation : supprimer l’immunosuppression. Med Sci (Paris) 2008 ; 24 : 689–691. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007 ; 7 : 585–598. [CrossRef] [PubMed] [Google Scholar]
  4. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006 ; 212 : 217–237. [CrossRef] [PubMed] [Google Scholar]
  5. Tarbell KV, Petit L, Zuo X, et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007 ; 204 : 191–201. [CrossRef] [PubMed] [Google Scholar]
  6. Miyara M, Amoura Z, Parizot C, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005 ; 175 : 8392–8400. [PubMed] [Google Scholar]
  7. Scalapino KJ, Tang Q, Bluestone JA, et al. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006 ; 177 : 1451–1459. [PubMed] [Google Scholar]
  8. Uhlig HH, Coombes J, Mottet C, et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006 ; 177 : 5852–5860. [PubMed] [Google Scholar]
  9. Morgan ME, Flierman R, van Duivenvoorde LM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005 ; 52 : 2212–2221. [CrossRef] [PubMed] [Google Scholar]
  10. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 2004 ; 16 : 249–256. [CrossRef] [PubMed] [Google Scholar]
  11. Masteller EL, Warner MR, Tang Q, et al. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005 ; 175 : 3053–3059. [PubMed] [Google Scholar]
  12. Godfrey WR, Ge YG, Spoden DJ, et al. In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004 ; 104 : 453–461. [CrossRef] [PubMed] [Google Scholar]
  13. Levings MK, Sangregorio R, Sartirana C, et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002 ; 196 : 1335–1346. [CrossRef] [PubMed] [Google Scholar]
  14. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004 ; 199 : 1455–1465. [CrossRef] [PubMed] [Google Scholar]
  15. Fisson S, Djelti F, Trenado A, et al. Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire. Eur J Immunol 2006 ; 36 : 817–827. [CrossRef] [PubMed] [Google Scholar]
  16. Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 2003 ; 102 : 2180–2186. [CrossRef] [PubMed] [Google Scholar]
  17. Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006 ; 177 : 8338–8347. [PubMed] [Google Scholar]
  18. Tilg H, van Montfrans C, van den Ende A, et al. Treatment of Crohn’s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002 ; 50 : 191–195. [CrossRef] [PubMed] [Google Scholar]
  19. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002 ; 195 : 603–616. [CrossRef] [PubMed] [Google Scholar]
  20. Groux H, O’Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 ; 389 : 737–742. [CrossRef] [PubMed] [Google Scholar]
  21. Wakkach A, Fournier N, Brun V, et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003 ; 18 : 605–617. [CrossRef] [PubMed] [Google Scholar]
  22. Bacchetta R, Gregori S, Serafini G, et al. Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica 2010 ; 95 : 2134–2143. [CrossRef] [PubMed] [Google Scholar]
  23. Brun V, Bastian H, Neveu V, Foussat A. Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int Immunopharmacol 2009 ; 9 : 609–613. [CrossRef] [PubMed] [Google Scholar]
  24. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009 ; 30 : 646–655. [CrossRef] [PubMed] [Google Scholar]
  25. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009 ; 106 : 1903–1908. [CrossRef] [Google Scholar]
  26. Kim HP, Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007 ; 204 : 1543–1551. [PubMed] [Google Scholar]
  27. Tao R, de Zoeten EF, Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007 ; 13 : 1299–1307. [CrossRef] [PubMed] [Google Scholar]
  28. Mekala DJ, Geiger TL. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Blood 2005 ; 105 : 2090–2092. [CrossRef] [PubMed] [Google Scholar]
  29. Urnov FD, Miller JC, Lee YL, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005 ; 435 : 646–651. [CrossRef] [PubMed] [Google Scholar]
  30. Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 ; 12 : 431–440. [CrossRef] [PubMed] [Google Scholar]
  31. Siri A, de Boysson H, Boursier G. Actualité sur les lymphocytes T régulateurs CD4+. Med Sci (Paris) 2012 ; 646–651. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  32. Mirabel M, Ferreira B, Sidi D, et al. Rhumatisme articulaire aigu : perspectives. Med Sci (Paris) 2012 ; 28 : 633–638. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.